4-[2-(p-dimethylaminophenyl)-4,5-diphenylimidazole-1-yl]-benzoic acid | 1172126-56-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-[2-(p-dimethylaminophenyl)-4,5-diphenylimidazole-1-yl]-benzoic acid
• 英文别名: 4-[2-[4-(Dimethylamino)phenyl]-4,5-diphenylimidazol-1-yl]benzoic acid
• CAS: 1172126-56-5
• 化学式: C₃₀H₂₅N₃O₂
• 分子量: 459.547
• InChiKey: ZZAFXAULRJNTPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  35
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  58.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-(4-(dimethylamino)benzylideneamino)benzoic acid 、 联苯甲酰 在 ammonium acetate 作用下， 反应 0.37h， 以92%的产率得到4-[2-(p-dimethylaminophenyl)-4,5-diphenylimidazole-1-yl]-benzoic acid
  参考文献：
  名称：

  微波辅助，无溶剂的平行合成方法，阐明了一些具有生物学意义的新型四芳基咪唑的反应机理

  摘要：

  Abstract The microwave assisted, solvent free, parallel syntheses of title compounds is described in this protocol. Twelve new tetraaryl imidazoles, which are incorporated with the chemotherapeutic pharmacophores, have been synthesized by adopting one pot multicomponent reaction. Attempt has been made to investigate the mechanism behind the formation of tetraaryl imidazoles by product identification method. The synthesized compounds were analyzed by physical and analytical data. The synthesized compounds were evaluated for their antibacterial, antitubercular, and short‐term anticancer activity. Compound 13 was found to be the candidate compound to investigate further for its potential anticancer activity. J. Heterocyclic Chem., 46, 278 (2009).

  DOI：

  10.1002/jhet.68

文献信息

• Microwave-assisted, solvent-free, parallel syntheses and elucidation of reaction mechanism for the formation of some novel tetraaryl imidazoles of biological interest
  作者：B. R. Prashantha Kumar、Gyanendra Kumar Sharma、S. Srinath、Mohamed Noor、B. Suresh、B. R. Srinivasa

  DOI：10.1002/jhet.68

  日期：2009.3

  Abstract The microwave assisted, solvent free, parallel syntheses of title compounds is described in this protocol. Twelve new tetraaryl imidazoles, which are incorporated with the chemotherapeutic pharmacophores, have been synthesized by adopting one pot multicomponent reaction. Attempt has been made to investigate the mechanism behind the formation of tetraaryl imidazoles by product identification method. The synthesized compounds were analyzed by physical and analytical data. The synthesized compounds were evaluated for their antibacterial, antitubercular, and short‐term anticancer activity. Compound 13 was found to be the candidate compound to investigate further for its potential anticancer activity. J. Heterocyclic Chem., 46, 278 (2009).